Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

Mike McCune, MD, PhD, head of the HIV Frontiers Program at the Gates Foundation, delivered an upbeat message at the ASGCT annual conference in New Orleans last week, showcasing the progress being made ...

Method reveals unexpected behavior in molecular crowding during cell state transitions and suggests density as a biomarker for functional precision medicine.

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Beyond the heart, the study hints that other transplantable organs could benefit from improved cold storage methods using a simple diuretic.

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...

Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are ...

AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels ...

CellProthera says it chose CELLforCURE by SEQENS as its CDMO for the quality of its infrastructure, equipment, and expertise of its team.